Despitea substantial recovery of sphingolipid compounds, GM3 (d18:1/24:1­(15z))remained consistently reduced in the recovered group, presenting itselfas a potential marker for COVID-19 mortality in elderly individuals.The persistent alterations of DBH protein and dopamine in both severeand recovered nonagenarian patients may be associated with long-termmanifestations, such as neurological damage. The gene discussed is DBH; the disease is COVID-19.